Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Sustained release ranolazine formulations

Sustained release ranolazine formulations

US Patent 6562826 · Granted May 13, 2003

Estimated economic value: $9,282,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Combination ALS therapy2019
Method of treating diabetes2014
Method of treating diabetes2014
Method of treating diabetes2012
Sustained release ranolazine formulations2005
Sustained release ranolazine formulations2005
Method and composition for restoring diuretic and renal function2004
Partial fatty acid oxidation inhibitors in the treatment of congestive heart fai2004
Sustained release ranolazine formulations2003
Sustained release ranolazine formulations2003
Method of treating arrhythmias2003
Partial fatty acid oxidation inhibitors in the treatment of congestive heart fai2003